Clinical Trials for Thyroid Cancer

1 Open Trial

Trial TypeProtocol No. &
Open Date
A Randomised, Double Blind Study to Compare the Complete Remission Rate Following a 5-Week Course of Selumetinib or Placebo and Single Dose Adjuvant Radioactive Iodine Therapy in Patients with Differentiated Thyroid Cancer

You do not have JavaScript enabled. This site works better with JavaScript turned on.